E1 and E2 Viral Proteins as Therapeutic Targets for Development of Antiviral Agents

doi 10.5772/intechopen.88697
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IntechOpen

Related search

Orthopoxvirus Targets for the Development of New Antiviral Agents

Antiviral Research
VirologyPharmacology
2012English

Antiviral Effect of N-Butyldeoxynojirimycin Against Bovine Viral Diarrhea Virus Correlates With Misfolding of E2 Envelope Proteins and Impairment of Their Association Into E1-E2 Heterodimers

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Tannins as Antiviral Agents

2020English

Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies With Additive Properties

PLoS ONE
Multidisciplinary
2016English

Emerging Antiviral Resistant Strains of Influenza a and the Potential Therapeutic Targets Within the Viral Ribonucleoprotein (vRNP) Complex

Virology Journal
VirologyInfectious Diseases
2014English

Polysaccharides as Antiviral Agents: Antiviral Activity of Carrageenan.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Formation of the Complex of Bovine Papillomavirus E1 and E2 Proteins Is Modulated by E2 Phosphorylation and Depends Upon Sequences Within the Carboxyl Terminus of E1.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Small G Proteins as Novel Therapeutic Targets in Cardiovascular Medicine

Physiology
Physiology
2003English

Antiviral Agents in Development for Zika Virus Infections

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy